Fat absorption and metabolism in bile duct ligated rats.
BACKGROUND
Bile excretion is obstructed in children with extrahepatic bile duct atresia (EHBA) resulting in fat malabsorption and disturbed lipid metabolism.


OBJECTIVE
Investigate if the bile duct ligated rat exhibits similar deviations as patients with EHBA under different feeding conditions.


METHODS
6 bile duct ligated Wistar rats and 12 matched paired controls were randomised over 3 feeding groups. Rats were killed 16 or 30 days postsurgery. Faeces, blood and livers were collected. Fat absorption was evaluated, markers for cholestasis and the fatty acid composition of serum phospholipids (PL) and cholesterol esters (CE) were determined. Fatty acid desaturation activities in liver microsomes were measured.


RESULTS
Cholestatic bile duct ligated rats have a lower fat absorption coefficient and a lower fraction of 18:2n-6 and 18:3n-3 in serum triglycerides than their controls. This demonstrates that bile duct ligated rats suffer from fat malabsorption. In contrast to the observations in serum triglycerides, 18:2n-6 and 18:3n-3 were not reduced in serum PL and CE of cholestatic rats. Overflow of 18:2n-6 rich biliary PL in the general circulation could contribute to this observation. In agreement with what was found in man, serum PL of cholestatic rats have a higher 16:0/18:0 ratio, increased monoenes and reduced unsaturated fatty acids. However, no differences were observed in microsomal desaturation activities.


CONCLUSIONS
Cholestatic bile duct ligated rats exhibit similar deviations in serum fatty acid composition as found in patients with EHBA, therefore they can be used as a model for this human disease.
De Vriese
S R
SR
Department of Endocrinology, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium. Stephanie.DeVriese@rug.ac.be
Savelii
J L
JL
Poisson
J P
JP
Narce
M
M
Kerremans
I
I
Lefebvre
R
R
Dhooge
W S
WS
De Greyt
W
W
Christophe
A B
AB
D000818:Animals; D001656:Biliary Atresia / Q000150:complications / Q000378:metabolism*; D016022:Case-Control Studies; D001651:Cholestasis, Extrahepatic / Q000209:etiology / Q000378:metabolism*; D004041:Dietary Fats / Q000493:pharmacokinetics*; D004195:Disease Models, Animal; D005227:Fatty Acids / Q000032:analysis*; D005243:Feces / Q000737:chemistry; D007408:Intestinal Absorption; D008026:Ligation; D008862:Microsomes, Liver / Q000378:metabolism; D010743:Phospholipids / Q000737:chemistry; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D014280:Triglycerides / Q000737:chemistry
D004041:Dietary Fats; D005227:Fatty Acids; D010743:Phospholipids; D014280:Triglycerides